April 29, 2021

Bexson Biomedical Granted USPTO Patent On Proprietary Ketamine Formulation

March 1, 2021

Bexson Biomedical Hires Veteran Medical Device Development Leader, Will Focus On New Dosing & Delivery Solutions For Controlled Substances

February 2, 2021

Bexson Biomedical Raises $4.8 Million In Oversubscribed Series A

September 21, 2020

Stevanato Group And Bexson Biomedical Announce Collaboration To Develop A Customized Wearable Ketamine Delivery Device

September 19, 2020

Forbes - This Wearable Ketamine Device Could be the Future of Pain Management

August 4, 2020

Bexson Biomedical To Co-Host Virtual Ketamine Conference

June 30, 2020

Bexson Biomedical Adds Industry Leaders Bill Carson And Noah Craft As Advisors

Presentations

April 2021 -- Investor Presentation